Is Fridays Legit? What to Know Before Signing Up

Direct Answer

Fridays is a real, well-documented telehealth platform, and among the companies covered in this library, it has one of the stronger legitimacy profiles: LegitScript certified, a verifiable US business address, licensed prescribers through OpenLoop Healthcare Partners, and a detailed hands-on review that scored it 97/100 on legitimacy and credentials. It offers both insurance-supported brand-name medications (Ozempic, Zepbound) and lower-cost compounded alternatives.

What Makes Fridays Different From Most Compounded-Only Platforms

Unlike many telehealth GLP-1 companies that only offer compounded medications, Fridays has a dedicated team that submits prior authorization requests and insurance appeals for brand-name Ozempic and Zepbound. If insurance approval isn't possible, patients can fall back to compounded semaglutide or tirzepatide at flat, published pricing. This dual pathway is a genuine structural difference from most competitors covered elsewhere in this library.

Pricing and Structure

Compounded semaglutide starts around $249-$279/month depending on the plan, with lower per-month rates on longer prepaid commitments. The subscription includes provider visits, dietitian coaching, and a fitness app. Fridays also offers non-GLP-1 services like NAD+ and testosterone therapy as add-ons. It serves 49 states, excluding Louisiana.

What Complaints Exist

Real complaints do appear in customer reviews, primarily about unclear billing communication (including at least one report of an unexpected $596 automatic renewal charge) and, in a smaller number of cases, individual patients reporting the medication didn't produce results for them specifically, a variability seen across GLP-1 treatment generally, not unique to Fridays.

A Note on Sourcing These Reviews

Several positive write-ups of Fridays, including video content, disclose affiliate commission relationships. This doesn't necessarily make specific facts wrong, LegitScript certification and the business address are independently verifiable, but weigh comparative claims accordingly.

Standard Compounded-Drug Caveats Still Apply

For the compounded medication pathway specifically, the standard caveats on our Compounded Semaglutide and Compounded Tirzepatide pages apply, these are not FDA-approved finished products.

References

• U.S. News & World Report: Fridays GLP-1 Weight Loss Review 2026
• Nutrition and Nourishment Collective: Fridays GLP-1 Review, hands-on legitimacy assessment
• ConsumerAffairs: Fridays Reviews

Related Resources

• How Does Commercial Insurance Prior Authorization Work?
• Compounded Semaglutide

Related Articles

• Is Brello Health Legit? What to Know Before Ordering
• Is Willow Legit? What to Know Before Ordering

Explore More

Explore the full GLP-1 Tracker knowledge base on DietApp.com

Get Started

Explore the GLP-1 Tracker knowledge base for accurate, sourced information on every GLP-1 option.

About DietApp.com

DietApp.com combines evidence-based GLP-1 medication education with practical treatment tracking tools. This article is for general informational purposes and is not medical or legal advice. Company reputations and reviews can change, verify current details directly before making any purchasing decision.